Skip to main content

Aura Biosciences, Inc. (AURA)

Aura Biosciences will go public soon. The estimated IPO date is October 29, 2021.
Stock Price: $14.00 - $16.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading on Oct 29, 2021.
Market Cap420.14M
Revenue (ttm)n/a
Net Income (ttm)-25.31M
Shares Out28.01M
EPS (ttm)-0.90
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About AURA

Aura Biosciences is a clinical-stage biotechnology company leveraging our novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology. Our proprietary platform enables the targeting of a broad range of solid tumors using Virus-Like Particles that can be conjugated with drugs or loaded with nucleic acids to create Virus-Like Drug Conjugates, or VDCs. Our VDCs are largely agnostic to tumor type and can recognize a surface marker that is spec...

IndustryBiotechnology
IPO DateOct 29, 2021
CEOElisabet de los Pinos, Ph.D.
Employees42
Stock ExchangeNASDAQ
Ticker SymbolAURA
Full Company Profile

Financial Performance

Financial Statements

News

Aura Biosciences IPO Registration Document (S-1)

Aura Biosciences, Inc. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC